So, the current products are Fanapt, Hetlioz and Ponvory. They expect to also have Bysanti, Tradipitant and Imsidlimab approved and selling by the end of 2026.
Right. The main appeal is the fact that the market is currently pricing it as if it will never make any cash flow ever again. So we only really need that to not be true, in order to double our money.
Hi, did you cash out completely out of this one?
Yeah I did. Found a better idea basically.
When you say 6 commercial products. Are those products based on Fanapt and HETLIOZ?
So, the current products are Fanapt, Hetlioz and Ponvory. They expect to also have Bysanti, Tradipitant and Imsidlimab approved and selling by the end of 2026.
Interesting. So we would be able to more accurately predict cash flows by then.
Right. The main appeal is the fact that the market is currently pricing it as if it will never make any cash flow ever again. So we only really need that to not be true, in order to double our money.